
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
William J. Gradishar, MD, FACP

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate
Ravi A. Madan, MD

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
Petros Grivas, MD, PhD

Liquid Biopsy: Advances in the Last Decade and Future Directions
Edgardo S. Santos Castillero, MD, FACP

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok